Putative Endogenous Mediators of Preconditioning-induced Ischemic Tolerance in Rat Brain Identified by Genomic and Proteomic Analysis
Overview
Affiliations
In brain, a brief ischemic episode induces protection against a subsequent severe ischemic insult. This phenomenon is known as preconditioning-induced neural ischemic tolerance. An understanding of the molecular mechanisms leading to preconditioning helps in identifying potential therapeutic targets for preventing the post-stroke brain damage. The present study conducted the genomic and proteomic analysis of adult rat brain as a function of time following preconditioning induced by a 10-min transient middle cerebral artery (MCA) occlusion. GeneChip analysis showed induction of 40 putative neuroprotective transcripts between 3 to 72 h after preconditioning. These included heat-shock proteins, heme oxygenases, metallothioneins, signal transduction mediators, transcription factors, ion channels and apoptosis/plasticity-related transcripts. Real-time PCR confirmed the GeneChip data for the transcripts up-regulated after preconditioning. Two-dimensional gel electrophoresis combined with MALDI-TOF analysis showed increased expression of HSP70, HSP27, HSP90, guanylyl cyclase, muskelin, platelet activating factor receptor and beta-actin at 24 h after preconditioning. HSP70 protein induction after preconditioning was localized in the cortical pyramidal neurons. The infarct volume induced by focal ischemia (1-h MCA occlusion) was significantly smaller (by 38 +/- 7%, p < 0.05) in rats subjected to preconditioning 3 days before the insult. Preconditioning also prevented several gene expression changes induced by focal ischemia.
Wang J, Sun X, Dai Y, Ma Y, Wang M, Li X Sci Rep. 2023; 13(1):14450.
PMID: 37660166 PMC: 10475051. DOI: 10.1038/s41598-023-41766-2.
Ischemic Tolerance-A Way to Reduce the Extent of Ischemia-Reperfusion Damage.
Burda R, Burda J, Morochovic R Cells. 2023; 12(6).
PMID: 36980225 PMC: 10047660. DOI: 10.3390/cells12060884.
Stroke Proteomics: From Discovery to Diagnostic and Therapeutic Applications.
Hochrainer K, Yang W Circ Res. 2022; 130(8):1145-1166.
PMID: 35420912 PMC: 9015233. DOI: 10.1161/CIRCRESAHA.122.320110.
Abbasi-Habashi S, Jickling G, Winship I Front Neurol. 2021; 12:746486.
PMID: 34956045 PMC: 8695500. DOI: 10.3389/fneur.2021.746486.
Neely M, Xie S, Prince L, Kim H, Tukker A, Aschner M Food Chem Toxicol. 2021; 154:112288.
PMID: 34089799 PMC: 8761390. DOI: 10.1016/j.fct.2021.112288.